Clinical Trial Update: Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing SGLT-2 inhibitors versus DPP-4 inhibitors to prevent disseminated intravascular coagulation in breast cancer patients; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DPP-4 inhibitor
• SGLT-2 inhibitor

Snippet

Sponsor: Tanta University | Conditions: Breast Cancer | Phase 4 | Status: NOT_YET_RECRUITING